BUSINESS● LOW4d ago · Oct 9, 2026, 8:43 AM
Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share
Seeking Alpha Tech · north america
Eli Lilly-backed TRexBio has priced its $117 million US initial public offering (IPO) at $14 per share. This indicates a routine corporate financing event for a biotech company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS19m agoWhy did Hong Kong’s 11 Skies fail and can the megaproject be rescued?South China Morning PostBUSINESS20m agoSingapore third-quarter GDP growth softens from four-year high but beats estimatesCNBC